These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22252957)

  • 1. Sonographic findings in a fatal case of transient myeloproliferative disorder.
    Goswami S; Phatak T
    J Clin Ultrasound; 2012; 40(6):378-80. PubMed ID: 22252957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the degree of fetal hepatosplenomegaly with transient abnormal myelopoiesis closely related to the postnatal severity of hematological abnormalities in Down syndrome?
    Ogawa M; Hosoya N; Sato A; Tanaka T
    Ultrasound Obstet Gynecol; 2004 Jul; 24(1):83-5. PubMed ID: 15229921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal hepatosplenomegaly: an isolated sonographic sign of trisomy 21 in a case of myeloproliferative disorder.
    Hartung J; Chaoui R; Wauer R; Bollmann R
    Ultrasound Obstet Gynecol; 1998 Jun; 11(6):453-5. PubMed ID: 9674095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal sonographic findings and hematological abnormalities in fetuses with transient abnormal myelopoiesis with Down syndrome.
    Hojo S; Tsukimori K; Kitade S; Nakanami N; Hikino S; Hara T; Wake N
    Prenat Diagn; 2007 Jun; 27(6):507-11. PubMed ID: 17345586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient myeloproliferative disorder in a newborn with Down syndrome.
    Rhoderick JA; Bradshaw WT
    Adv Neonatal Care; 2008 Aug; 8(4):208-18; quiz 219-20. PubMed ID: 18690081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Ductus venosus blood velocity in myeloproliferative disorders.
    Smrcek JM; Gembruch U
    Ultrasound Obstet Gynecol; 2001 Nov; 18(5):547. PubMed ID: 11844183
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypoechoic hepatomegaly associated with transient abnormal myelopoiesis provides clues to trisomy 21 in the third-trimester fetus.
    Hamada H; Yamada N; Watanabe H; Okuno S; Fujiki Y; Kubo T
    Ultrasound Obstet Gynecol; 2001 May; 17(5):442-4. PubMed ID: 11380972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrops fetalis in a neonate with down syndrome, transient myeloproliferative disorder and hepatic fibrosis.
    Anuk D; Tarcan A; Alioglu B; Avci Z; Haberal N; Ozyurek E; Ozbek N
    Fetal Pediatr Pathol; 2007; 26(5-6):223-8. PubMed ID: 18363154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient myeloproliferative disorder in neonates with and without Down syndrome: a tale of 2 syndromes.
    Apollonsky N; Shende A; Ouansafi I; Brody J; Atlas M; Aygun B
    J Pediatr Hematol Oncol; 2008 Nov; 30(11):860-4. PubMed ID: 18989165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for transient myeloproliferative disorder in a premature infant with Down syndrome.
    Oztekin O; Kalay S; Tezel G; Tayfun F; Kupesiz A; Hangul M; Akcakus M; Oygur N
    J Clin Pharm Ther; 2013 Jun; 38(3):262-4. PubMed ID: 23510328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrauterine diagnosis and management of transient myeloproliferative disorder.
    Strobelt N; Ghidini A; Locatelli A; Vergani P; Mariani S; Biondi A
    Am J Perinatol; 1995 Mar; 12(2):132-4. PubMed ID: 7779196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Congenital leukaemia and transient myeloproliferative disorder: diagnostic difficulties--case reports].
    Jackowska T; Steczowicz M; Pawelec K; Pacholska J
    Med Wieku Rozwoj; 2006; 10(3 Pt 1):595-601. PubMed ID: 17317890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome.
    Zipursky A; Brown EJ; Christensen H; Doyle J
    Clin Lab Med; 1999 Mar; 19(1):157-67, vii. PubMed ID: 10403079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal hydrops and hepatosplenomegaly in the second half of pregnancy: a sign of myeloproliferative disorder in fetuses with trisomy 21.
    Smrcek JM; Baschat AA; Germer U; Gloeckner-Hofmann K; Gembruch U
    Ultrasound Obstet Gynecol; 2001 May; 17(5):403-9. PubMed ID: 11380964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin involvement in Down syndrome transient abnormal myelopoiesis.
    Krawczyk J; McDermott M; Irvine AD; O'Marcaigh A; Storey L; Smith O
    Br J Haematol; 2012 May; 157(3):280. PubMed ID: 22385123
    [No Abstract]   [Full Text] [Related]  

  • 16. Transient myeloproliferative disorder and non-immune hydrops fetalis in a neonate with trisomy 21.
    Hon KL; Leung TY
    Hong Kong Med J; 2014 Feb; 20(1):78.e3-e4. PubMed ID: 24473698
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factors for early death in transient myeloproliferative disorder without phenotypic features of Down syndrome: a case report and literature review.
    Kawase K; Azuma E; Ohshita H; Tanaka T; Hanada Y; Sasaki T; Sugimoto M; Togawa T; Kouwaki M; Ito T; Hirayama M; Koyama N
    J Pediatr Hematol Oncol; 2012 Aug; 34(6):475-9. PubMed ID: 22510770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vesiculopustular eruption in a neonate with trisomy 21 syndrome as a clue of transient myeloproliferative disorders.
    Piersigilli F; Diociaiuti A; Boldrini R; Auriti C; Curci M; El Hachem M; Seganti G
    Cutis; 2010 Jun; 85(6):286-8. PubMed ID: 20666188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital leukaemia and the neonatal myeloproliferative disorders associated with Down's syndrome.
    Weinstein HJ
    Clin Haematol; 1978 Feb; 7(1):147-54. PubMed ID: 148990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient abnormal myelopoiesis accompanied by hepatic fibrosis in two infants with Down syndrome.
    Yagihashi N; Watanabe K; Yagihashi S
    J Clin Pathol; 1995 Oct; 48(10):973-5. PubMed ID: 8537505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.